Form 4: Alector Insider Acquires RSUs

Alector, Inc. reports that Grace Wong-Sarad, Principal Accounting Officer, acquired 20,000 restricted stock units.

Summary

• Grace Wong-Sarad, Principal Accounting Officer at Alector, Inc., acquired 20,000 restricted stock units (RSUs) on July 9, 2026.
• These RSUs are subject to a vesting schedule, with 12 equal quarterly installments beginning on September 1, 2026.
• The acquisition was made under a Rule 10b5-1(c) plan, indicating it was pre-arranged to comply with insider trading regulations.
• Following this transaction, Wong-Sarad beneficially owns 115,461 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction under a pre-arranged plan, providing no new financial or strategic information about the company's performance.

Positives

• Insider acquisition of stock units can signal confidence in the company's future prospects.
• The transaction was conducted under a Rule 10b5-1(c) plan, demonstrating adherence to compliance and governance standards.
• The vesting schedule indicates a long-term commitment to the company by the reporting person.

Negatives

• The filing does not provide details on the market value of the acquired RSUs at the time of the transaction, only that the acquisition price was $0, typical for RSU grants.
• No financial performance metrics or strategic updates are included in this Form 4 filing.

Risks

• The vesting schedule implies that the reporting person's full benefit from these RSUs is contingent on continued employment and company performance over the next three years.
• Potential future stock price volatility could impact the ultimate value of the acquired RSUs.

Future Outlook

The vesting schedule for the acquired RSUs begins on September 1, 2026, and continues in 12 equal quarterly installments, indicating a forward-looking commitment tied to future performance.

Industry Context

StockSavvy.ai notes that insider acquisitions of equity, particularly under Rule 10b5-1 plans, are common in the biotechnology and pharmaceutical sectors as a means for executives to align their interests with shareholders and demonstrate long-term commitment.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition by a key officer may be viewed positively as a sign of confidence, though it does not directly impact current share value.
• Employees: Standard RSU grants are a common form of employee compensation and retention in the industry.
• Management: Reinforces the alignment of executive interests with long-term company performance.

Next Steps

• Vesting of restricted stock units will commence quarterly starting September 1, 2026.
• Continued monitoring of Alector, Inc.'s stock performance and future SEC filings.

Key Dates

Keywords

Form 4, Insider Transaction, Alector Inc., ALEC, Restricted Stock Units, RSU, Beneficial Ownership, Rule 10b5-1, Grace Wong-Sarad, Principal Accounting Officer